Literature DB >> 15736479

Imbalance of cell proliferation and apoptosis during progression of lung carcinomas.

Jürgen Mattern1, Manfred Volm.   

Abstract

To evaluate the relationship between cell proliferation and apoptosis during progression of lung carcinomas, immunohistochemistry for proliferating cell nuclear antigen (PCNA) and the in situ end labelling (TUNEL) method for identifying apoptotic bodies were performed on paraffin sections from 135 lung carcinomas. These results were correlated with the corresponding tumor volumes as a model of disease progression in lung tumors. We found that, with increasing tumor volume, the proliferation rate decreased significantly, whereas the apoptotic rate increased. There was no relationship between apoptotic and proliferative indices except in carcinomas with a tumor volume between 51 and 100 cm3. These data suggest that progression of lung carcinomas, i.e. the increase in tumor volume, is accompanied by an increase in apoptosis rather than an increase in cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15736479

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  15 in total

1.  Protein signature for non-small cell lung cancer prognosis.

Authors:  Wei Liu; Yong Wu; Libo Wang; Ling Gao; Yingping Wang; Xiaoliang Liu; Kai Zhang; Jena Song; Hongxia Wang; Thomas A Bayer; Laurel Glaser; Yezhou Sun; Weijia Zhang; Michael Cutaia; David Y Zhang; Fei Ye
Journal:  Am J Cancer Res       Date:  2014-05-26       Impact factor: 6.166

2.  Nanotherapy silencing the interleukin-8 gene produces regression of prostate cancer by inhibition of angiogenesis.

Authors:  Ravikumar Aalinkeel; Bindukumar Nair; Chih-Kuang Chen; Supriya D Mahajan; Jessica L Reynolds; Hanguang Zhang; Haotian Sun; Donald E Sykes; Kailash C Chadha; Steven G Turowski; Katelyn D Bothwell; Mukund Seshadri; Chong Cheng; Stanley A Schwartz
Journal:  Immunology       Date:  2016-08       Impact factor: 7.397

3.  Correlation of expression of Akt1 and E2F1 and their phosphorylated forms in breast cancer patients with clinicopathological parameters.

Authors:  Shadia M Al-Bahlani; Ritu Lakhtakia; Samiya S Al-Jaaidi; Shadia S Al-Sinawi; Shaymaa G Abd-Elmoety; Murtadha Al-Khabori; Anjum H A Osman; Khalid Al-Baimani; Asem A Shalaby
Journal:  J Mol Histol       Date:  2021-04-13       Impact factor: 2.611

4.  Translation in solid cancer: are size-based response criteria an anachronism?

Authors:  M Fernandes; D Rosel; J Brábek
Journal:  Clin Transl Oncol       Date:  2014-07-30       Impact factor: 3.405

5.  Patterns of Apoptosis and Proliferation throughout the Biennial Reproductive Cycle of Viviparous Female Typhlonectes compressicauda (Amphibia, Gymnophiona).

Authors:  Michel Raquet; Claire Brun; Jean-Marie Exbrayat
Journal:  Int J Mol Sci       Date:  2016-12-22       Impact factor: 5.923

6.  CCL28 promotes breast cancer growth and metastasis through MAPK-mediated cellular anti-apoptosis and pro-metastasis.

Authors:  Xiao Li Yang; Kai Yi Liu; Feng Juan Lin; Hui Min Shi; Zhou Luo Ou
Journal:  Oncol Rep       Date:  2017-07-07       Impact factor: 3.906

7.  Calpain-1 Expression in Triple-Negative Breast Cancer: A Potential Prognostic Factor Independent of the Proliferative/Apoptotic Index.

Authors:  Shadia M Al-Bahlani; Ruqaya M Al-Rashdi; Shiyam Kumar; Shadia S Al-Sinawi; Maiya A Al-Bahri; Asem A Shalaby
Journal:  Biomed Res Int       Date:  2017-04-27       Impact factor: 3.411

8.  Apoptin Regulates Apoptosis and Autophagy by Modulating Reactive Oxygen Species (ROS) Levels in Human Liver Cancer Cells.

Authors:  Yiquan Li; Yilong Zhu; Jinbo Fang; Wenjie Li; Shanzhi Li; Xing Liu; Zirui Liu; Gaojie Song; Chao Shang; Jianan Cong; Bing Bai; Lili Sun; Ningyi Jin; Xiao Li
Journal:  Front Oncol       Date:  2020-06-25       Impact factor: 6.244

9.  Puerarin 6″-O-xyloside possesses significant antitumor activities on colon cancer through inducing apoptosis.

Authors:  Xiao-Lan Zhang; Bin-Bin Wang; Jian-Shu Mo
Journal:  Oncol Lett       Date:  2018-08-24       Impact factor: 2.967

10.  Moxidectin inhibits glioma cell viability by inducing G0/G1 cell cycle arrest and apoptosis.

Authors:  Dandan Song; Hongsheng Liang; Bo Qu; Yijing Li; Jingjing Liu; Chen Chen; Daming Zhang; Xiangtong Zhang; Aili Gao
Journal:  Oncol Rep       Date:  2018-07-12       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.